Rosalind A. Eeles

88.2k total citations · 5 hit papers
361 papers, 17.7k citations indexed

About

Rosalind A. Eeles is a scholar working on Genetics, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Rosalind A. Eeles has authored 361 papers receiving a total of 17.7k indexed citations (citations by other indexed papers that have themselves been cited), including 186 papers in Genetics, 123 papers in Pulmonary and Respiratory Medicine and 106 papers in Molecular Biology. Recurrent topics in Rosalind A. Eeles's work include BRCA gene mutations in cancer (139 papers), Prostate Cancer Treatment and Research (99 papers) and Prostate Cancer Diagnosis and Treatment (67 papers). Rosalind A. Eeles is often cited by papers focused on BRCA gene mutations in cancer (139 papers), Prostate Cancer Treatment and Research (99 papers) and Prostate Cancer Diagnosis and Treatment (67 papers). Rosalind A. Eeles collaborates with scholars based in United Kingdom, United States and Canada. Rosalind A. Eeles's co-authors include Douglas F. Easton, Audrey Ardern‐Jones, Zsofia Kote‐Jarai, Maggie Watson, Magali Olivier, Pierre Hainaut, D. Gareth Evans, Khan Ma, Monica Hollstein and Curtis C. Harris and has published in prestigious journals such as Science, The Lancet and Nature Communications.

In The Last Decade

Rosalind A. Eeles

350 papers receiving 17.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The IARC TP53 database: New online mutation analysis and recommendations to users

2002 980 citations Rosalind A. Eeles et al. profile →
Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS)

2005 765 citations Caroline Boggis, Douglas F. Easton et al. profile →
Prostate cancer

2015 708 citations Chris Parker, Rosalind A. Eeles et al. profile →
Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

1998 649 citations Rosalind A. Eeles, Mitch Dowsett et al. profile →
Stereotactic body radiotherapy for oligometastases

2012 374 citations Alison Tree, Vincent Khoo et al. profile →

Peers

Countries citing papers authored by Rosalind A. Eeles

Since Specialization

Citations

This map shows the geographic impact of Rosalind A. Eeles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosalind A. Eeles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosalind A. Eeles more than expected).

Fields of papers citing papers by Rosalind A. Eeles

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosalind A. Eeles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosalind A. Eeles. The network helps show where Rosalind A. Eeles may publish in the future.

Co-authorship network of co-authors of Rosalind A. Eeles

This figure shows the co-authorship network connecting the top 25 collaborators of Rosalind A. Eeles. A scholar is included among the top collaborators of Rosalind A. Eeles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosalind A. Eeles. Rosalind A. Eeles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The landscape of microbial associations in human cancer 2025 ·Science Translational Medicine ·Abraham Gihawi, Henry M. Wood, J. W. Clark, Justin O’Grady, Rosalind A. Eeles, David C. Wedge, (unknown), Gkikas Magiorkinis, Andrew Schache, Liam Masterson, (unknown), Tim R. Fenton, Terence M. Jones, Adrienne M. Flanagan, (unknown), Alex Rubinsteyn, Rachel Hurst, Colin S. Cooper, Daniel Brewer	2
2	1656TiP The STAMPEDE2 niraparib-abiraterone acetate + prednisolone trial: A phase III, randomised, open-label trial in patients with metastatic prostate cancer (mPC) with a deleterious alteration in a homologous recombination repair (HRR) gene starting androgen deprivation therapy (ADT) 2024 ·Annals of Oncology ·Sarah Howlett, (unknown), Louise Brown, Claire Amos, Peter Dutey‐Magni, (unknown), Laura E. O’Shea, Catherine A. Hogan, Anna Wingate, (unknown), Rosalind A. Eeles, Michael Hubank, Phillip Williams, William Cross, (unknown), Nigel Clarke, (unknown), Nicholas D. James, Emily Grist, (unknown)	1
3	Online Provision of BRCA1 and BRCA2 Health Information: A Search Engine Driven Systematic Web-Based Analysis 2024 ·Cancers ·(unknown), (unknown), (unknown), Monika Sobočan, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Rosa Legood, Rosalind A. Eeles, D. Gareth Evans, (unknown), Ranjit Manchanda	0
4	BRCA awareness and testing experience in the UK Jewish population: a qualitative study 2024 ·Journal of Medical Genetics ·(unknown), (unknown), (unknown), Monika Sobočan, (unknown), Michail Sideris, (unknown), (unknown), Rosalind A. Eeles, D. Gareth Evans, Samantha L. Quaife, Ranjit Manchanda	1
5	Evaluating Germline Testing Panels in Southern African Males With Advanced Prostate Cancer 2023 ·Journal of the National Comprehensive Cancer Network ·(unknown), (unknown), Shingai B.A. Mutambirwa, (unknown), Zsofia Kote‐Jarai, Weerachai Jaratlerdsiri, Rosalind A. Eeles, Riana Bornman, Vanessa M. Hayes	13
6	Functional Analysis Identifies Damaging CHEK2 Missense Variants Associated with Increased Cancer Risk 2021 ·Cancer Research ·Rick A.C.M. Boonen, Wouter W. Wiegant, (unknown), Bas Vroling, (unknown), Zsofia Kote‐Jarai, Martina Mijušković, Simona Cristea, (unknown), Tom van Wezel, Niko Beerenwinkel, Rosalind A. Eeles, Peter Devilee, Maaike P.G. Vreeswijk, Giancarlo Marra, Haico van Attikum	33
7	Oncologically Relevant Findings Reporting and Data System (ONCO-RADS): Guidelines for the Acquisition, Interpretation, and Reporting of Whole-Body MRI for Cancer Screening 2021 ·Radiology ·Giuseppe Petralia, Dow‐Mu Koh, (unknown), (unknown), Rosalind A. Eeles, David S. Karow, Gladys Lo, Christina Messiou, Evis Sala, Hebert Alberto Vargas, Fabio Zugni, Anwar R. Padhani	39
8	Identification of Novel Susceptibility Loci and Genes for Prostate Cancer Risk: A Transcriptome-Wide Association Study in Over 140,000 European Descendants 2019 ·Cancer Research ·Lang Wu, Jifeng Wang, Qiuyin Cai, Taylor B. Cavazos, Nima C. Emami, Jirong Long, Xiao‐Ou Shu, Yingchang Lu, Xingyi Guo, Joshua A. Bauer, Bogdan Paşaniuc, Kathryn L. Penney, Matthew L. Freedman, Zsofia Kote‐Jarai, Esther M. John, Christopher A. Haiman, Rosalind A. Eeles, Wei Zheng	37
9	Analysis of Over 140,000 European Descendants Identifies Genetically Predicted Blood Protein Biomarkers Associated with Prostate Cancer Risk 2019 ·Cancer Research ·Lang Wu, Xiang Shu, Jiandong Bao, Xingyi Guo, Zsofia Kote‐Jarai, Christopher A. Haiman, Rosalind A. Eeles, Wei Zheng	16
10	Patterns of recurrence after prostate bed radiotherapy 2019 ·Radiotherapy and Oncology ·Douglas Brand, (unknown), David P. Dearnaley, Rosalind A. Eeles, Robert Huddart, Vincent Khoo, Julia Murray, Yae‐Eun Suh, Alison Tree, Nicholas van As, Chris Parker	15
11	Runs of homozygosity and testicular cancer risk 2019 ·Andrology ·Chey Loveday, Amit Sud, Kevin Litchfield, Max Levy, (unknown), Peter Broderick, Zsofia Kote‐Jarai, Alison M. Dunning, Kenneth Muir, Julian Peto, Rosalind A. Eeles, Douglas F. Easton, Darshna Dudakia, Nick Orr, Nora Pashayan, (unknown), Robert Huddart, Richard S. Houlston, Clare Turnbull	4
12	RAZOR: A Phase II Open Randomized Trial of Screening Plus Goserelin and Raloxifene Versus Screening Alone in Premenopausal Women at Increased Risk of Breast Cancer 2017 ·Cancer Epidemiology Biomarkers & Prevention ·Anthony Howell, Linda Ashcroft, Lesley Fallowfield, Diana Eccles, Rosalind A. Eeles, Ann Ward, Adam R. Brentnall, Mitch Dowsett, Jack Cuzick, (unknown), Caroline Boggis, (unknown), Jamie C. Sergeant, Judith E. Adams, D. Gareth Evans	4
13	Genetic Variants in Epigenetic Pathways and Risks of Multiple Cancers in the GAME-ON Consortium 2017 ·Cancer Epidemiology Biomarkers & Prevention ·Réka Tóth, Dominique Scherer, Linda E. Kelemen, Angela Risch, Aditi Hazra, Yesilda Balavarca, Jean‐Pierre J. Issa, Vı́ctor Moreno, Rosalind A. Eeles, Shuji Ogino, Xifeng Wu, Yuanqing Ye, Rayjean J. Hung, Ellen L. Goode, Cornelia M. Ulrich, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	11
14	Use of a Novel Nonparametric Version of DEPTH to Identify Genomic Regions Associated with Prostate Cancer Risk 2016 ·Cancer Epidemiology Biomarkers & Prevention ·Robert J. MacInnis, Daniel F. Schmidt, Enes Makalic, Gianluca Severi, Liesel M. FitzGerald, Matthias Reumann, (unknown), Adam Kowalczyk, (unknown), Benjamin Goudey, Guoqi Qian, Minh Bui, Daniel J. Park, (unknown), Melissa C. Southey, Ali Amin Al Olama, Zsofia Kote‐Jarai, Rosalind A. Eeles, John L. Hopper, Graham G. Giles	3
15	Implications of polygenic risk-stratified screening for prostate cancer on overdiagnosis 2015 ·Genetics in Medicine ·Nora Pashayan, Stephen Duffy, David E. Neal, Freddie C. Hamdy, Jenny Donovan, Richard M. Martin, Patricia Harrington, Sara Benlloch, Ali Amin Al Olama, Mitul Shah, Zsofia Kote‐Jarai, Douglas F. Easton, Rosalind A. Eeles, Paul D.P. Pharoah	69
16	Genetic Variation in Prostate-Specific Antigen–Detected Prostate Cancer and the Effect of Control Selection on Genetic Association Studies 2014 ·Cancer Epidemiology Biomarkers & Prevention ·Duleeka Knipe, David M. Evans, John P. Kemp, Rosalind A. Eeles, Douglas F. Easton, Zsofia Kote‐Jarai, Ali Amin Al Olama, Sara Benlloch, Jenny Donovan, Freddie C. Hamdy, David E. Neal, George Davey Smith, Mark Lathrop, Richard M. Martin	25
17	Risk-Reducing Salpingo-Oophorectomy for the Prevention of BRCA1- and BRCA2-Associated Breast and Gynecologic Cancer: A Multicenter, Prospective Study 2008 ·Journal of Clinical Oncology ·Noah D. Kauff, Susan M. Domchek, Tara M. Friebel, Mark E. Robson, Johanna Lee, Judy E. Garber, Claudine Isaacs, D. Gareth Evans, Henry T. Lynch, Rosalind A. Eeles, Susan L. Neuhausen, Mary B. Daly, Ellen Matloff, Joanne L. Blum, Paul Sabbatini, Richard R. Barakat, Clifford A. Hudis, Larry Norton, Kenneth Offit, Timothy R. Rebbeck	381
18	Does Genetic Counseling Have Any Impact on Management of Breast Cancer Risk? 2005 ·Genetic Testing ·Maggie Watson, Kathryn M. Kash, Judi Homewood, S. Ebbs, Victoria Murday, Rosalind A. Eeles	28
19	Non-Uptake of Predictive Genetic Testing for BRCA1/2 among Relatives of Known Carriers: Attributes, Cancer Worry, and Barriers to Testing in a Multicenter Clinical Cohort 2004 ·Genetic Testing ·Claire Foster, D. Gareth Evans, Rosalind A. Eeles, Diana Eccles, S. Ashley, Lucy Brooks, T Cole, Jackie Cook, R Davidson, Helen Gregory, James Mackay, P. Morrison, Maggie Watson	56
20	Genetic Testing for Women Previously Diagnosed with Breast/Ovarian Cancer: Examining the Impact of BRCA1 and BRCA2 Mutation Searching 2002 ·Genetic Testing ·Nina Hallowell, Claire Foster, Audrey Ardern‐Jones, Rosalind A. Eeles, Victoria Murday, Maggie Watson	69

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact